| Antigen processing and presentation |
1.76 |
1.54e-1 |
60/78 (76.92%) |
HSPA6;TAPBP;HSPA1A;...
|
| Graft-versus-host disease |
1.56 |
5.23e-1 |
32/42 (76.19%) |
GZMB;PRF1;HLA-C;...
|
| Allograft rejection |
1.49 |
5.11e-1 |
32/38 (84.21%) |
GZMB;PRF1;HLA-C;...
|
| African trypanosomiasis |
1.46 |
4.96e-1 |
32/37 (86.49%) |
HBB;IDO1;VCAM1;...
|
| Homologous recombination |
1.42 |
5.91e-1 |
35/41 (85.37%) |
RPA2;BABAM2;NBN;...
|
| Autoimmune thyroid disease |
1.42 |
5.16e-1 |
46/53 (86.79%) |
GZMB;PRF1;HLA-C;...
|
| Progesterone-mediated oocyte maturation |
1.40 |
5.06e-1 |
75/100 (75%) |
IGF1;ADCY1;CDK2;...
|
| Type I diabetes mellitus |
1.39 |
4.83e-1 |
38/43 (88.37%) |
GZMB;PRF1;HLA-C;...
|
| beta-Alanine metabolism |
1.39 |
4.37e-1 |
25/30 (83.33%) |
CNDP2;ALDH7A1;ALDH3A1;...
|
| Histidine metabolism |
1.38 |
4.10e-1 |
16/22 (72.73%) |
CNDP2;AOC1;ALDH7A1;...
|
| Protein digestion and absorption |
1.35 |
4.56e-1 |
78/103 (75.73%) |
COL5A2;COL1A1;COL14A1;...
|
| DNA replication |
1.32 |
5.43e-1 |
34/36 (94.44%) |
RPA2;POLA1;MCM6;...
|
| Legionellosis |
1.31 |
5.32e-1 |
51/57 (89.47%) |
HSPA6;HSPA1A;CASP1;...
|
| Leukocyte transendothelial migration |
1.30 |
5.06e-1 |
90/114 (78.95%) |
VCAM1;PIK3CB;THY1;...
|
| Mucin type O-glycan biosynthesis |
1.30 |
4.86e-1 |
20/36 (55.56%) |
GALNT10;GALNT3;GALNT6;...
|
| Hypertrophic cardiomyopathy |
1.29 |
4.92e-1 |
81/90 (90%) |
IGF1;TNNC1;TTN;...
|
| Endocrine and other factor-regulated calcium reabsorpti... |
1.28 |
4.75e-1 |
49/53 (92.45%) |
ESR1;CLTB;KL;...
|
| Synthesis and degradation of ketone bodies |
1.28 |
4.50e-1 |
9/10 (90%) |
HMGCL;BDH1
|
| Viral protein interaction with cytokine and cytokine re... |
1.28 |
4.29e-1 |
84/100 (84%) |
PPBP;CCL5;CXCL14;...
|
| Ribosome biogenesis in eukaryotes |
1.28 |
4.21e-1 |
52/108 (48.15%) |
DROSHA;NAT10;MDN1;...
|
| Apoptosis |
1.28 |
4.08e-1 |
126/168 (75%) |
CSF2RB;GZMB;PRF1;...
|
| Dilated cardiomyopathy |
1.26 |
4.33e-1 |
86/96 (89.58%) |
IGF1;ADCY1;TNNC1;...
|
| Notch signaling pathway |
1.25 |
4.43e-1 |
49/59 (83.05%) |
NOTCH2;JAG2;NCOR2;...
|
| Other types of O-glycan biosynthesis |
1.25 |
4.27e-1 |
29/47 (61.7%) |
GALNT10;GALNT3;GALNT6;...
|
| Longevity regulating pathway |
1.24 |
4.37e-1 |
90/151 (59.6%) |
IGF1;HSPA6;HSPA1A;...
|
| Melanoma |
1.24 |
4.31e-1 |
68/72 (94.44%) |
IGF1;PDGFD;CDH1;...
|
| Sphingolipid metabolism |
1.21 |
4.92e-1 |
32/49 (65.31%) |
GALC;SPTLC2;CERS2;...
|
| Salmonella infection |
1.18 |
5.63e-1 |
198/249 (79.52%) |
AHNAK;AHNAK2;CASP1;...
|
| Phagosome |
1.18 |
5.45e-1 |
118/152 (77.63%) |
FCGR3B;SFTPA2;TUBB2A;...
|
| Lysosome |
1.12 |
6.20e-1 |
115/128 (89.84%) |
GALC;CLTB;CTSW;...
|
| Choline metabolism in cancer |
-1.46 |
1.94e-1 |
84/98 (85.71%) |
EIF4EBP1;MAP2K1;MAPK8;...
|
| Aldosterone-regulated sodium reabsorption |
-1.46 |
1.98e-1 |
34/37 (91.89%) |
SGK1;NR3C2;PIK3R1;...
|
| mTOR signaling pathway |
-1.47 |
1.87e-1 |
114/154 (74.03%) |
FZD5;RRAGA;EIF4EBP1;...
|
| PPAR signaling pathway |
-1.48 |
1.89e-1 |
66/74 (89.19%) |
SLC27A6;SCP2;ILK;...
|
| Chemical carcinogenesis |
-1.49 |
1.76e-1 |
186/281 (66.19%) |
NFKB1;GSTA3;RB1;...
|
| Pantothenate and CoA biosynthesis |
-1.49 |
1.83e-1 |
14/21 (66.67%) |
COASY;ALDH2;AASDHPPT;...
|
| Mitophagy |
-1.49 |
1.89e-1 |
56/68 (82.35%) |
MITF;PINK1;RHOT1;...
|
| Alcoholism |
-1.49 |
1.96e-1 |
86/186 (46.24%) |
TH;PRKACA;MAP2K1;...
|
| Insulin signaling pathway |
-1.50 |
1.88e-1 |
121/137 (88.32%) |
AKT2;CBL;CBLB;...
|
| Basal transcription factors |
-1.50 |
1.93e-1 |
37/45 (82.22%) |
TAF4B;GTF2H5;TBP;...
|
| Neurotrophin signaling pathway |
-1.52 |
1.79e-1 |
107/119 (89.92%) |
RPS6KA3;AKT2;CALML4;...
|
| MicroRNAs in cancer |
-1.52 |
1.86e-1 |
146/310 (47.1%) |
MAP2K1;TP63;CDK6;...
|
| Retinol metabolism |
-1.53 |
1.84e-1 |
41/68 (60.29%) |
AOX1;DHRS9;UGT2B4;...
|
| Drug metabolism |
-1.53 |
1.90e-1 |
78/151 (51.66%) |
XDH;AOX1;UGT2B4;...
|
| Pentose and glucuronate interconversions |
-1.54 |
1.86e-1 |
17/34 (50%) |
RPE;UGT2B4;DCXR;...
|
| Collecting duct acid secretion |
-1.55 |
1.90e-1 |
22/27 (81.48%) |
ATP4A;ATP6V1A;ATP6V0C;...
|
| FoxO signaling pathway |
-1.55 |
2.00e-1 |
118/131 (90.08%) |
MAP2K1;CHUK;MAPK8;...
|
| C-type lectin receptor signaling pathway |
-1.59 |
1.48e-1 |
93/104 (89.42%) |
RRAS2;SYK;AKT2;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.59 |
1.52e-1 |
49/77 (63.64%) |
UGT2B4;CYP1A2;GSTA4;...
|
| Steroid hormone biosynthesis |
-1.60 |
1.48e-1 |
43/61 (70.49%) |
HSD17B7;COMT;CYP11B1;...
|
| Nitrogen metabolism |
-1.61 |
1.46e-1 |
16/17 (94.12%) |
CPS1;CA4;GLUD2;...
|
| Oxidative phosphorylation |
-1.62 |
1.52e-1 |
93/133 (69.92%) |
ATP6V1F;NDUFA9;ATP5F1C;...
|
| Autophagy |
-1.63 |
1.42e-1 |
113/169 (66.86%) |
EIF2S1;RRAS2;DAPK2;...
|
| Mineral absorption |
-1.64 |
1.44e-1 |
48/60 (80%) |
SLC30A1;HMOX1;SLC8A2;...
|
| Renal cell carcinoma |
-1.65 |
1.39e-1 |
68/69 (98.55%) |
EPAS1;AKT2;TGFB2;...
|
| Ferroptosis |
-1.67 |
1.35e-1 |
36/41 (87.8%) |
PCBP2;ATG5;SLC7A11;...
|
| Complement and coagulation cascades |
-1.69 |
1.53e-1 |
76/85 (89.41%) |
CFHR2;CFHR4;C7;...
|
| Non-alcoholic fatty liver disease |
-1.72 |
1.43e-1 |
126/155 (81.29%) |
CEBPA;NDUFB7;CYC1;...
|
| Arginine biosynthesis |
-1.76 |
1.78e-1 |
17/22 (77.27%) |
GPT;CPS1;ARG1;...
|
| Proximal tubule bicarbonate reclamation |
-1.84 |
1.23e-1 |
21/23 (91.3%) |
GLUD2;ATP1B3;PCK2;...
|
